Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Acq. announced
CC transcript

BALCHEM CORP (BCPC) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/22/2023 4 Fischer David B (Director) has filed a Form 4 on BALCHEM CORP
Txns: Sold 3,000 shares @ $127.007, valued at $381k
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/19/2022 4 Harris Theodore L (Chairman, President & CEO) has filed a Form 4 on BALCHEM CORP
Txns: Granted 130,000 options to buy @ $0
08/16/2022 4 van Gunsteren Job Leonard (Vice President) has filed a Form 4 on BALCHEM CORP
Txns: Exercised 1,000 shares @ $58.52, valued at $58.5k
Sold 1,000 shares @ $131.1207, valued at $131.1k
08/09/2022 4 van Gunsteren Job Leonard (Vice President) has filed a Form 4 on BALCHEM CORP
Txns: Exercised 2,629 shares @ $50.32, valued at $132.3k
Sold 2,629 shares @ $127.0079, valued at $333.9k
08/05/2022 4 van Gunsteren Job Leonard (Vice President) has filed a Form 4 on BALCHEM CORP
Txns: Exercised 1,200 shares @ $38.1, valued at $45.7k
Exercised 1,000 shares @ $58.52, valued at $58.5k
Sold 2,200 shares @ $126.0029, valued at $277.2k
Sold 1,401 shares @ $125.0165, valued at $175.1k
Exercised 1,371 shares @ $50.32, valued at $69k
Sold 1,371 shares @ $127.0026, valued at $174.1k
02/16/2022 4 Hyde James C (Sr. Vice President) has filed a Form 4 on BALCHEM CORP
Txns: Paid exercise price by delivering 348 shares @ $139.38, valued at $48.5k
02/16/2022 4 Stach Mark A (General Counsel) has filed a Form 4 on BALCHEM CORP
Txns: Paid exercise price by delivering 302 shares @ $139.38, valued at $42.1k
02/16/2022 4 Backus William A. (Chief Accounting Officer) has filed a Form 4 on BALCHEM CORP
Txns: Paid exercise price by delivering 470 shares @ $139.38, valued at $65.5k
02/16/2022 4 Harris Theodore L (CEO & President) has filed a Form 4 on BALCHEM CORP
Txns: Paid exercise price by delivering 2,400 shares @ $139.38, valued at $334.5k
02/16/2022 4 TELEVANTOS JOHN Y (Director) has filed a Form 4 on BALCHEM CORP
Txns: Paid exercise price by delivering 359 shares @ $139.38, valued at $50k
02/15/2022 4 Hyde James C (Sr. Vice President) has filed a Form 4 on BALCHEM CORP
Txns: Paid exercise price by delivering 318 shares @ $137.73, valued at $43.8k
02/15/2022 4 Stach Mark A (General Counsel) has filed a Form 4 on BALCHEM CORP
Txns: Paid exercise price by delivering 997 shares @ $137.73, valued at $137.3k
02/15/2022 4 Backus William A. (Chief Accounting Officer) has filed a Form 4 on BALCHEM CORP
Txns: Paid exercise price by delivering 1,961 shares @ $137.73, valued at $270.1k
02/15/2022 4 Bengtsson Carl Martin (CFO) has filed a Form 4 on BALCHEM CORP
Txns: Paid exercise price by delivering 664 shares @ $137.73, valued at $91.5k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy